Burke Steven Keith, SVP and Chief Medical Officer of Akebia Therapeutics ($AKBA), sold shares on the open market three times in the last year for a total of $94,000. His most recent sale was on February 2, 2026. These AKBA insider sales rank 9,677th out of 11,678 individuals, well below the average of $8.6 million over 6.4 transactions. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 20701 | $1.39 | 948,432.0000 | 274,372,722 | 2.14% | 0.01% |
| Feb. 2, 2026 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 25375 | $1.39 | 969,133.0000 | 274,372,722 | 2.55% | 0.01% |
| Feb. 2, 2026 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 21582 | $1.39 | 994,508.0000 | 274,372,722 | 2.12% | 0.01% |
| Jan. 30, 2026 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | A | Common Stock | 204000 | $0.00 | 1,016,090.0000 | 274,372,722 | 25.12% | 0.07% |
| Jan. 30, 2026 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | A | Stock Option (Right to buy) | 320000 | $0.00 | 320,000.0000 | 274,372,722 | 9999.99% | 0.12% |
| March 3, 2025 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 7144 | $1.83 | 809,090.0000 | 210,946,658 | 0.88% | 0.00% |
| Jan. 31, 2025 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | A | Common Stock | 194900 | $0.00 | 866,740.0000 | 210,946,658 | 29.01% | 0.09% |
| Feb. 3, 2025 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 23270 | $2.10 | 843,470.0000 | 210,946,658 | 2.68% | 0.01% |
| Feb. 3, 2025 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 27236 | $2.10 | 816,234.0000 | 210,946,658 | 3.23% | 0.01% |
| Jan. 31, 2025 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | A | Stock Option (Right to buy) | 292300 | $0.00 | 292,300.0000 | 210,946,658 | 9999.99% | 0.14% |
| Aug. 25, 2023 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 27000 | $1.15 | 668,840.0000 | 0 | 3.88% | 0.00% |
| Feb. 29, 2024 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 7169 | $1.58 | 695,840.0000 | 187,465,448 | 1.02% | 0.00% |
| Feb. 27, 2024 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 8367 | $1.52 | 703,009.0000 | 187,465,448 | 1.18% | 0.00% |
| Feb. 1, 2024 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 24311 | $1.68 | 711,376.0000 | 187,465,448 | 3.30% | 0.01% |
| Jan. 31, 2024 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | A | Stock Option (Right to buy) | 303300 | $0.00 | 303,300.0000 | 187,465,448 | 9999.99% | 0.16% |
| Jan. 31, 2024 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | A | Common Stock | 202200 | $0.00 | 735,687.0000 | 187,465,448 | 37.90% | 0.11% |
| May 16, 2023 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 63567 | $1.07 | 530,487.0000 | 0 | 10.70% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 6613 | $0.88 | 601,564.0000 | 0 | 1.09% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 6400 | $0.88 | 595,164.0000 | 0 | 1.06% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 1110 | $0.88 | 594,054.0000 | 0 | 0.19% | 0.00% |
| Feb. 27, 2023 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S | Common Stock | 7539 | $0.81 | 608,177.0000 | 0 | 1.22% | 0.00% |
| Jan. 31, 2023 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | A | Stock Option (Right to buy) | 294300 | $0.00 | 294,300.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Akebia Therapeutics, Inc. | $AKBA | Burke Steven Keith | SVP, Chief Medical Officer | A | Common Stock | 196200 | $0.00 | 615,716.0000 | 0 | 46.77% | 0.00% |